FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979304829> ?p ?o ?g. }

• W2979304829 abstract "Abstract Abstract 40 Pharmacologic inhibition of BCR-ABL, using clinically active ATP-competitive inhibitors imatinib, nilotinib, and dasatinib, has been used to investigate BCR-ABL kinase activated signaling pathways. However, these agents show cross reactivity with other kinases (e.g. Kit, PDGFR, SRC family members), and their multi-targeted nature complicates assigning biological effects to the inhibition of a specific kinase target. Allosteric kinase inhibitors modulate the catalytic activity of protein kinases by binding to a site distant from the active site and inducing a protein conformation that inhibits kinase activity. These agents show promise as clinical agents and may offer advantages over ATP-competitive inhibitors in studying the function of specific kinases because they exploit binding sites and regulatory mechanisms that are unique to a particular kinase. GNF-2, a mono-selective BCR-ABL inhibitor that targets wild-type BCR-ABL and many clinically relevant imatinib resistant mutants, was recently discovered and provided the first demonstration that c-ABL kinase activity could be modulated by an inhibitor that binds outside the ATP or substrate binding sites. GNF-2 binds to a myristoyl-binding pocket in the C-lobe of the c-ABL kinase domain but its mechanism of inhibiting specific BCR-ABL kinase targets remains unclear. We previously reported that BCR-ABL activates an autocrine IGF-1 pro-survival signaling pathway in CML blast crisis cells through HCK-mediated activation of STAT5b. As GNF-2 is known to inhibit STAT5b phosphorylation, and HCK myristolyation is known to regulate its cellular localization, we hypothesized that GNF-2 inhibits BCR-ABL activation of HCK by binding to the ABL myristoyl-binding pocket and blocking access to the HCK myristoyl moiety. In support of this hypothesis, we now show that GNF-2 inhibits HCK phosphorylation and IGF-1 activation, but not HCK binding to BCR-ABL. To confirm the importance of the HCK myristoyl moiety in HCK activation, we mutated the myristoyl attachment site at position 2 in HCK from glycine to alanine. The mutant G2A HCK still interacted with BCR-ABL in co-immunoprecipitation assays but showed significantly lower levels of phosphorylation compared to wild-type HCK. To confirm that the decrease in phosphorylation was not due to mislocalization of G2A HCK, we mutated the myristoylation binding pocket of BCR-ABL by changing glutamic acid at position 505 to lysine. Similar to G2A HCK, E505K BCR-ABL still interacted with HCK, but the phosphorylation levels of HCK were dramatically reduced. To confirm that the HCK myristoyl moiety directly interacted with the ABL myristoyl-binding pocket, we used fluorescent spectroscopy to measure the ability of a myristoylated peptide corresponding to the six N-terminal amino acids of HCK to displace GNF-2. The fluorescence of GNF-2 is enhanced when it associates with the myristoyl-binding pocket of ABL. Using this assay, we calculated the Kd of GNF-2 to be 180 nM. We then assayed the ability of myristolyated HCK peptide to displace GNF-2 from ABL. We calculated the IC50 of the myristolyated HCK peptide to be 25 μM when ABL was saturated with 300 nM GNF-2. Myristate showed an IC50 of 213 μM, which is ∼ 10-fold higher than the myristoylated peptide. No binding was detected between the non-myristoylated peptide and ABL. Together, our study highlights a novel acquired function resulting from the fusion of BCR to the N-terminus of ABL, which converts the myristoyl-binding pocket in ABL from a negative regulator of kinase activity to an HCK activation motif that activates downstream IGF-1 signaling. These results also reveal the mechanism of action of the mono-selective BCR-ABL inhibitor GNF-2 and highlight the ABL myristoyl-binding pocket as a therapeutic target for inhibiting BCR-ABL activity. Disclosures: No relevant conflicts of interest to declare." @default.
• W2979304829 created "2019-10-18" @default.
• W2979304829 creator A5009678966 @default.
• W2979304829 creator A5012409078 @default.
• W2979304829 creator A5036702140 @default.
• W2979304829 creator A5058680570 @default.
• W2979304829 creator A5084732910 @default.
• W2979304829 date "2009-11-20" @default.
• W2979304829 modified "2023-10-01" @default.
• W2979304829 title "GNF-2, An Allosteric BCR-ABL Inhibitor, Identifies a Novel Myristoylation-Mediated Mechanism Regulating the Ability of BCR-ABL to Activate HCK and IGF-1 Signaling." @default.
• W2979304829 doi "https://doi.org/10.1182/blood.v114.22.40.40" @default.
• W2979304829 hasPublicationYear "2009" @default.
• W2979304829 type Work @default.
• W2979304829 sameAs 2979304829 @default.
• W2979304829 citedByCount "2" @default.
• W2979304829 countsByYear W29793048292019 @default.
• W2979304829 countsByYear W29793048292021 @default.
• W2979304829 crossrefType "journal-article" @default.
• W2979304829 hasAuthorship W2979304829A5009678966 @default.
• W2979304829 hasAuthorship W2979304829A5012409078 @default.
• W2979304829 hasAuthorship W2979304829A5036702140 @default.
• W2979304829 hasAuthorship W2979304829A5058680570 @default.
• W2979304829 hasAuthorship W2979304829A5084732910 @default.
• W2979304829 hasConcept C108636557 @default.
• W2979304829 hasConcept C11960822 @default.
• W2979304829 hasConcept C125418893 @default.
• W2979304829 hasConcept C150109051 @default.
• W2979304829 hasConcept C166342909 @default.
• W2979304829 hasConcept C170493617 @default.
• W2979304829 hasConcept C184235292 @default.
• W2979304829 hasConcept C185592680 @default.
• W2979304829 hasConcept C2777583451 @default.
• W2979304829 hasConcept C2778729363 @default.
• W2979304829 hasConcept C2779536868 @default.
• W2979304829 hasConcept C3019892230 @default.
• W2979304829 hasConcept C42362537 @default.
• W2979304829 hasConcept C502942594 @default.
• W2979304829 hasConcept C55493867 @default.
• W2979304829 hasConcept C62478195 @default.
• W2979304829 hasConcept C77207865 @default.
• W2979304829 hasConcept C86803240 @default.
• W2979304829 hasConcept C95444343 @default.
• W2979304829 hasConcept C97029542 @default.
• W2979304829 hasConceptScore W2979304829C108636557 @default.
• W2979304829 hasConceptScore W2979304829C11960822 @default.
• W2979304829 hasConceptScore W2979304829C125418893 @default.
• W2979304829 hasConceptScore W2979304829C150109051 @default.
• W2979304829 hasConceptScore W2979304829C166342909 @default.
• W2979304829 hasConceptScore W2979304829C170493617 @default.
• W2979304829 hasConceptScore W2979304829C184235292 @default.
• W2979304829 hasConceptScore W2979304829C185592680 @default.
• W2979304829 hasConceptScore W2979304829C2777583451 @default.
• W2979304829 hasConceptScore W2979304829C2778729363 @default.
• W2979304829 hasConceptScore W2979304829C2779536868 @default.
• W2979304829 hasConceptScore W2979304829C3019892230 @default.
• W2979304829 hasConceptScore W2979304829C42362537 @default.
• W2979304829 hasConceptScore W2979304829C502942594 @default.
• W2979304829 hasConceptScore W2979304829C55493867 @default.
• W2979304829 hasConceptScore W2979304829C62478195 @default.
• W2979304829 hasConceptScore W2979304829C77207865 @default.
• W2979304829 hasConceptScore W2979304829C86803240 @default.
• W2979304829 hasConceptScore W2979304829C95444343 @default.
• W2979304829 hasConceptScore W2979304829C97029542 @default.
• W2979304829 hasLocation W29793048291 @default.
• W2979304829 hasOpenAccess W2979304829 @default.
• W2979304829 hasPrimaryLocation W29793048291 @default.
• W2979304829 hasRelatedWork W1976954193 @default.
• W2979304829 hasRelatedWork W1992251850 @default.
• W2979304829 hasRelatedWork W1997790249 @default.
• W2979304829 hasRelatedWork W1999440346 @default.
• W2979304829 hasRelatedWork W2000673625 @default.
• W2979304829 hasRelatedWork W2041460867 @default.
• W2979304829 hasRelatedWork W2057147161 @default.
• W2979304829 hasRelatedWork W2059411813 @default.
• W2979304829 hasRelatedWork W2078135059 @default.
• W2979304829 hasRelatedWork W2082097264 @default.
• W2979304829 hasRelatedWork W2085839369 @default.
• W2979304829 hasRelatedWork W2089834044 @default.
• W2979304829 hasRelatedWork W2158243489 @default.
• W2979304829 hasRelatedWork W2166922628 @default.
• W2979304829 hasRelatedWork W2331701350 @default.
• W2979304829 hasRelatedWork W2341765492 @default.
• W2979304829 hasRelatedWork W2587111775 @default.
• W2979304829 hasRelatedWork W2979571032 @default.
• W2979304829 hasRelatedWork W3168609611 @default.
• W2979304829 hasRelatedWork W601527880 @default.
• W2979304829 isParatext "false" @default.
• W2979304829 isRetracted "false" @default.
• W2979304829 magId "2979304829" @default.
• W2979304829 workType "article" @default.